<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/florence-italy/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/florence-italy</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Fri, 15 May 2026 17:31:33 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole]]></title>
		<link>https://www.thaipr.net/en/general_en/3356364</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 10 Jul 2023 08:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3356364</guid>

					<description><![CDATA[<p>The awards ceremony at the Roman Theatre was also attended by  the Minister for Sport and Youth, Andrea Abodi Yesterday evening, the grand finale of the XXVII edition of the Menarini International Fair Play Awards was warmly greeted by over one thousand spectators at the Roman Theatre in Fiesole. The event, organised by the Menarini Fair Play Foundation and focused on [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3356364">Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Fair Play Menarini International Awards, the 2023 edition starts with the talk show &#8220;The Champions tell their Stories&#8221; in Piazza della Signoria, Florence]]></title>
		<link>https://www.thaipr.net/en/general_en/3353958</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 03 Jul 2023 13:30:10 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3353958</guid>

					<description><![CDATA[<p>The countdown has begun to the XXVII edition of the Fair Play Menarini International Awards. Tomorrow, Monday, July 3rd, the 2023 edition of the event, dedicated to the sporting values of ethics, fair play and respect, will officially begin in the city of Florence, with the eagerly-awaited talk show &#8220;The Champions tell their Stories&#8221;. The show, which is [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3353958">Fair Play Menarini International Awards, the 2023 edition starts with the talk show &#8220;The Champions tell their Stories&#8221; in Piazza della Signoria, Florence</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[BOTTICELLI, THE INQUIETUDE AND THE BEAUTY &#8211; Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance]]></title>
		<link>https://www.thaipr.net/en/general_en/3337422</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 17 May 2023 08:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3337422</guid>

					<description><![CDATA[<p>Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master of beauty.  With his &#8220;Venuses,&#8221; he unknowingly established a canon of perfection that closely reflects that of modern day.  Yet, he was a mysterious and disquieted figure: despite his timeless reputation, his paintings still [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3337422">BOTTICELLI, THE INQUIETUDE AND THE BEAUTY &#8211; Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[The Dates of the XXVII Edition of the International Fair Play Menarini Awards]]></title>
		<link>https://www.thaipr.net/en/general_en/3326936</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 17 Apr 2023 16:28:22 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3326936</guid>

					<description><![CDATA[<p>Preparations are already underway for the International Fair Play Menarini Awards. This year,  the event that pays tribute to athletes who demonstrate values such as ethics, loyalty and respect both in sport and in life, is in its XXVII edition and will host international sporting legends over the course of the three-day event in Florence and Fiesole. &#8220;It is an honour [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3326936">The Dates of the XXVII Edition of the International Fair Play Menarini Awards</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant&#8217;s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting]]></title>
		<link>https://www.thaipr.net/en/health_en/3276787</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 06 Dec 2022 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3276787</guid>

					<description><![CDATA[<p>Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors Elacestrant side effects were manageable and consistent with previously reported results  Results demonstrate that elacestrant may have the potential to become a new standard of care as a monotherapy endocrine sequencing [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3276787">Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant&#8217;s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Sport&#8217;s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award]]></title>
		<link>https://www.thaipr.net/en/health_en/3211677</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 11 Jul 2022 10:26:43 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3211677</guid>

					<description><![CDATA[<p>Intense emotions and immense satisfaction were in the air during the final event of the XXVI Fair Play Menarini International Award. Yesterday evening, the award ceremony for the winners of the 2022 edition in Castiglion Fiorentino (Arezzo) drew an enjoyable end to this celebration of the values of sportsmanship, organised by the Fair Play Menarini Foundation. Ethics, loyalty and [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3211677">Sport&#8217;s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant]]></title>
		<link>https://www.thaipr.net/en/health_en/3145390</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 18 Jan 2022 13:30:46 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3145390</guid>

					<description><![CDATA[<p>The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant infections, directly at the moment of the positivity test. To support this recommendation, Menarini offers CoronaMeltVAR, a CE-IVD Real-Time PCR kit based [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3145390">Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia]]></title>
		<link>https://www.thaipr.net/en/health_en/3118436</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 05 Nov 2021 16:18:03 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3118436</guid>

					<description><![CDATA[<p>The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual PIM/FLT3 inhibitor, in-licensed by Menarini from Ryvu Therapeutics, and currently investigated in the DIAMOND-01 trial as a single agent for [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3118436">Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Sporting Legends Shine on a Magical Evening at the Menarini Fair Play Awards]]></title>
		<link>https://www.thaipr.net/en/sport_en/3094298</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 03 Sep 2021 15:10:09 +0700</pubDate>
				<category>sport_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/sport_en/3094298</guid>

					<description><![CDATA[<p>The event dedicated to ethics and fair play celebrated its 25th anniversary with a grand finale that welcomed great Italian and international sporting stars The XXV Menarini International Fair Play awards ceremony saw a genuine outpouring of emotions, with illustrious guests and true legends of Italian and world sport. This 2021 edition was truly special [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/sport_en/3094298">Sporting Legends Shine on a Magical Evening at the Menarini Fair Play Awards</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees]]></title>
		<link>https://www.thaipr.net/en/health_en/3050710</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 30 Apr 2021 12:50:50 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3050710</guid>

					<description><![CDATA[<p>PQE Group, a consulting company in the pharmaceutical and biomedical sector headquartered in Florence, Italy with 26 offices worldwide, has announced important changes. By the end of 2020, a year marked by the global pandemic, the company&#8217;s turnover increased by 10% and allowed it to grow by expanding its staff and opening new foreign offices. [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3050710">2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)]]></title>
		<link>https://www.thaipr.net/en/health_en/3021410</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 22 Jan 2021 11:50:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3021410</guid>

					<description><![CDATA[<p>&#8211; ELZONRIS is the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, in Europe &#8211; Approval is based on the results of the largest prospective clinical trial ever conducted in patients with treatment-naïve or previously-treated BPDCN The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3021410">Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)]]></title>
		<link>https://www.thaipr.net/en/health_en/3000782</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 16 Nov 2020 14:19:53 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3000782</guid>

					<description><![CDATA[<p>&#8211; The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN &#8211; If approved by the European Commission, ELZONRIS will be the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, in Europe The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3000782">CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
